nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—CYP3A4—Calcitriol—psoriasis	0.0719	0.103	CbGbCtD
Linagliptin—CYP3A4—Methoxsalen—psoriasis	0.0559	0.0804	CbGbCtD
Linagliptin—ABCB1—Mycophenolate mofetil—psoriasis	0.0536	0.0771	CbGbCtD
Linagliptin—ABCB1—Betamethasone—psoriasis	0.046	0.0661	CbGbCtD
Linagliptin—ABCB1—Prednisolone—psoriasis	0.0454	0.0653	CbGbCtD
Linagliptin—ABCB1—Hydrocortisone—psoriasis	0.043	0.0619	CbGbCtD
Linagliptin—ABCB1—Prednisone—psoriasis	0.0429	0.0616	CbGbCtD
Linagliptin—ABCB1—Cyclosporine—psoriasis	0.0406	0.0584	CbGbCtD
Linagliptin—CYP3A4—Cholecalciferol—psoriasis	0.0371	0.0533	CbGbCtD
Linagliptin—CYP3A4—Mycophenolate mofetil—psoriasis	0.0321	0.0462	CbGbCtD
Linagliptin—CYP3A4—Triamcinolone—psoriasis	0.0321	0.0462	CbGbCtD
Linagliptin—CYP3A4—Betamethasone—psoriasis	0.0276	0.0396	CbGbCtD
Linagliptin—CYP3A4—Prednisolone—psoriasis	0.0272	0.0391	CbGbCtD
Linagliptin—ABCB1—Dexamethasone—psoriasis	0.0268	0.0385	CbGbCtD
Linagliptin—CYP3A4—Hydrocortisone—psoriasis	0.0258	0.0371	CbGbCtD
Linagliptin—CYP3A4—Prednisone—psoriasis	0.0257	0.0369	CbGbCtD
Linagliptin—CYP3A4—Cyclosporine—psoriasis	0.0244	0.035	CbGbCtD
Linagliptin—ABCB1—Methotrexate—psoriasis	0.0215	0.0309	CbGbCtD
Linagliptin—CYP3A4—Dexamethasone—psoriasis	0.016	0.023	CbGbCtD
Linagliptin—Headache—Clobetasol propionate—psoriasis	0.000946	0.00311	CcSEcCtD
Linagliptin—Hypoglycaemia—Cyclosporine—psoriasis	0.000946	0.00311	CcSEcCtD
Linagliptin—Diabetes mellitus—Hydrocortisone—psoriasis	0.000943	0.0031	CcSEcCtD
Linagliptin—Skin disorder—Calcitriol—psoriasis	0.000931	0.00306	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Methoxsalen—psoriasis	0.000928	0.00305	CcSEcCtD
Linagliptin—Hypoglycaemia—Mycophenolate mofetil—psoriasis	0.000923	0.00303	CcSEcCtD
Linagliptin—Skin exfoliation—Dexamethasone—psoriasis	0.000922	0.00303	CcSEcCtD
Linagliptin—Skin exfoliation—Betamethasone—psoriasis	0.000922	0.00303	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Mycophenolic acid—psoriasis	0.000916	0.00301	CcSEcCtD
Linagliptin—Cough—Acitretin—psoriasis	0.000912	0.003	CcSEcCtD
Linagliptin—Cough—Fluocinolone Acetonide—psoriasis	0.000909	0.00299	CcSEcCtD
Linagliptin—Weight increased—Mycophenolic acid—psoriasis	0.000897	0.00295	CcSEcCtD
Linagliptin—Myalgia—Acitretin—psoriasis	0.00089	0.00292	CcSEcCtD
Linagliptin—Arthralgia—Acitretin—psoriasis	0.00089	0.00292	CcSEcCtD
Linagliptin—Diabetes mellitus—Triamcinolone—psoriasis	0.000888	0.00292	CcSEcCtD
Linagliptin—Arthralgia—Fluocinolone Acetonide—psoriasis	0.000887	0.00292	CcSEcCtD
Linagliptin—Infestation NOS—Mycophenolic acid—psoriasis	0.000879	0.00289	CcSEcCtD
Linagliptin—Infestation—Mycophenolic acid—psoriasis	0.000879	0.00289	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Calcitriol—psoriasis	0.000873	0.00287	CcSEcCtD
Linagliptin—Rash—Beclomethasone—psoriasis	0.000867	0.00285	CcSEcCtD
Linagliptin—Dermatitis—Beclomethasone—psoriasis	0.000866	0.00285	CcSEcCtD
Linagliptin—Headache—Beclomethasone—psoriasis	0.000861	0.00283	CcSEcCtD
Linagliptin—Rash—Fluocinonide—psoriasis	0.000859	0.00282	CcSEcCtD
Linagliptin—Dermatitis—Fluocinonide—psoriasis	0.000858	0.00282	CcSEcCtD
Linagliptin—Urinary tract infection—Mycophenolic acid—psoriasis	0.000855	0.00281	CcSEcCtD
Linagliptin—Urticaria—Methoxsalen—psoriasis	0.000854	0.00281	CcSEcCtD
Linagliptin—Headache—Fluocinonide—psoriasis	0.000854	0.00281	CcSEcCtD
Linagliptin—Infection—Acitretin—psoriasis	0.000847	0.00278	CcSEcCtD
Linagliptin—Infection—Fluocinolone Acetonide—psoriasis	0.000845	0.00278	CcSEcCtD
Linagliptin—Skin disorder—Acitretin—psoriasis	0.000828	0.00272	CcSEcCtD
Linagliptin—Constipation—Calcitriol—psoriasis	0.00082	0.00269	CcSEcCtD
Linagliptin—Diabetes mellitus—Dexamethasone—psoriasis	0.000806	0.00265	CcSEcCtD
Linagliptin—Diabetes mellitus—Betamethasone—psoriasis	0.000806	0.00265	CcSEcCtD
Linagliptin—Skin exfoliation—Prednisone—psoriasis	0.000803	0.00264	CcSEcCtD
Linagliptin—Hypersensitivity—Methoxsalen—psoriasis	0.000792	0.0026	CcSEcCtD
Linagliptin—Pancreatitis—Cyclosporine—psoriasis	0.000782	0.00257	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Acitretin—psoriasis	0.000777	0.00255	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Fluocinolone Acetonide—psoriasis	0.000775	0.00255	CcSEcCtD
Linagliptin—Pancreatitis—Mycophenolate mofetil—psoriasis	0.000763	0.00251	CcSEcCtD
Linagliptin—Urticaria—Calcitriol—psoriasis	0.000761	0.0025	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Cyclosporine—psoriasis	0.000741	0.00244	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Acitretin—psoriasis	0.000736	0.00242	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000734	0.00241	CcSEcCtD
Linagliptin—Constipation—Acitretin—psoriasis	0.000729	0.0024	CcSEcCtD
Linagliptin—Weight increased—Cyclosporine—psoriasis	0.000726	0.00239	CcSEcCtD
Linagliptin—Pancreatitis—Prednisolone—psoriasis	0.000712	0.00234	CcSEcCtD
Linagliptin—Mediastinal disorder—Mycophenolic acid—psoriasis	0.000711	0.00234	CcSEcCtD
Linagliptin—Infestation—Cyclosporine—psoriasis	0.000711	0.00234	CcSEcCtD
Linagliptin—Infestation NOS—Cyclosporine—psoriasis	0.000711	0.00234	CcSEcCtD
Linagliptin—Weight increased—Mycophenolate mofetil—psoriasis	0.000708	0.00233	CcSEcCtD
Linagliptin—Hypersensitivity—Calcitriol—psoriasis	0.000706	0.00232	CcSEcCtD
Linagliptin—Diabetes mellitus—Prednisone—psoriasis	0.000702	0.00231	CcSEcCtD
Linagliptin—Pancreatitis—Hydrocortisone—psoriasis	0.000695	0.00228	CcSEcCtD
Linagliptin—Infestation NOS—Mycophenolate mofetil—psoriasis	0.000694	0.00228	CcSEcCtD
Linagliptin—Infestation—Mycophenolate mofetil—psoriasis	0.000694	0.00228	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.000694	0.00228	CcSEcCtD
Linagliptin—Urinary tract infection—Cyclosporine—psoriasis	0.000691	0.00227	CcSEcCtD
Linagliptin—Malnutrition—Mycophenolic acid—psoriasis	0.000687	0.00226	CcSEcCtD
Linagliptin—Rash—Methoxsalen—psoriasis	0.000678	0.00223	CcSEcCtD
Linagliptin—Dermatitis—Methoxsalen—psoriasis	0.000677	0.00223	CcSEcCtD
Linagliptin—Urticaria—Acitretin—psoriasis	0.000677	0.00223	CcSEcCtD
Linagliptin—Urinary tract infection—Mycophenolate mofetil—psoriasis	0.000674	0.00222	CcSEcCtD
Linagliptin—Headache—Methoxsalen—psoriasis	0.000674	0.00221	CcSEcCtD
Linagliptin—Skin exfoliation—Methotrexate—psoriasis	0.000671	0.0022	CcSEcCtD
Linagliptin—Infection—Hydroxyurea—psoriasis	0.000665	0.00219	CcSEcCtD
Linagliptin—Back pain—Mycophenolic acid—psoriasis	0.000665	0.00218	CcSEcCtD
Linagliptin—Weight increased—Prednisolone—psoriasis	0.000661	0.00217	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Hydrocortisone—psoriasis	0.000659	0.00217	CcSEcCtD
Linagliptin—Diarrhoea—Calcitriol—psoriasis	0.000656	0.00216	CcSEcCtD
Linagliptin—Pancreatitis—Triamcinolone—psoriasis	0.000654	0.00215	CcSEcCtD
Linagliptin—Skin disorder—Hydroxyurea—psoriasis	0.00065	0.00214	CcSEcCtD
Linagliptin—Weight increased—Hydrocortisone—psoriasis	0.000645	0.00212	CcSEcCtD
Linagliptin—Infestation NOS—Hydrocortisone—psoriasis	0.000632	0.00208	CcSEcCtD
Linagliptin—Infestation—Hydrocortisone—psoriasis	0.000632	0.00208	CcSEcCtD
Linagliptin—Hypersensitivity—Acitretin—psoriasis	0.000628	0.00206	CcSEcCtD
Linagliptin—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000626	0.00206	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Triamcinolone—psoriasis	0.00062	0.00204	CcSEcCtD
Linagliptin—Weight increased—Triamcinolone—psoriasis	0.000607	0.002	CcSEcCtD
Linagliptin—Rash—Calcitriol—psoriasis	0.000604	0.00199	CcSEcCtD
Linagliptin—Dermatitis—Calcitriol—psoriasis	0.000604	0.00198	CcSEcCtD
Linagliptin—Headache—Calcitriol—psoriasis	0.0006	0.00197	CcSEcCtD
Linagliptin—Cough—Mycophenolic acid—psoriasis	0.0006	0.00197	CcSEcCtD
Linagliptin—Diabetes mellitus—Methotrexate—psoriasis	0.000586	0.00193	CcSEcCtD
Linagliptin—Myalgia—Mycophenolic acid—psoriasis	0.000585	0.00192	CcSEcCtD
Linagliptin—Arthralgia—Mycophenolic acid—psoriasis	0.000585	0.00192	CcSEcCtD
Linagliptin—Diarrhoea—Acitretin—psoriasis	0.000583	0.00192	CcSEcCtD
Linagliptin—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000582	0.00191	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000581	0.00191	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000578	0.0019	CcSEcCtD
Linagliptin—Mediastinal disorder—Cyclosporine—psoriasis	0.000575	0.00189	CcSEcCtD
Linagliptin—Constipation—Hydroxyurea—psoriasis	0.000572	0.00188	CcSEcCtD
Linagliptin—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.000561	0.00184	CcSEcCtD
Linagliptin—Infection—Mycophenolic acid—psoriasis	0.000557	0.00183	CcSEcCtD
Linagliptin—Malnutrition—Cyclosporine—psoriasis	0.000556	0.00183	CcSEcCtD
Linagliptin—Weight increased—Betamethasone—psoriasis	0.000551	0.00181	CcSEcCtD
Linagliptin—Weight increased—Dexamethasone—psoriasis	0.000551	0.00181	CcSEcCtD
Linagliptin—Skin disorder—Mycophenolic acid—psoriasis	0.000545	0.00179	CcSEcCtD
Linagliptin—Malnutrition—Mycophenolate mofetil—psoriasis	0.000542	0.00178	CcSEcCtD
Linagliptin—Rash—Acitretin—psoriasis	0.000538	0.00177	CcSEcCtD
Linagliptin—Dermatitis—Acitretin—psoriasis	0.000537	0.00177	CcSEcCtD
Linagliptin—Rash—Fluocinolone Acetonide—psoriasis	0.000536	0.00176	CcSEcCtD
Linagliptin—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000536	0.00176	CcSEcCtD
Linagliptin—Headache—Acitretin—psoriasis	0.000534	0.00176	CcSEcCtD
Linagliptin—Headache—Fluocinolone Acetonide—psoriasis	0.000533	0.00175	CcSEcCtD
Linagliptin—Back pain—Mycophenolate mofetil—psoriasis	0.000524	0.00172	CcSEcCtD
Linagliptin—Pancreatitis—Prednisone—psoriasis	0.000517	0.0017	CcSEcCtD
Linagliptin—Immune system disorder—Hydrocortisone—psoriasis	0.000513	0.00168	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.000511	0.00168	CcSEcCtD
Linagliptin—Angioedema—Cyclosporine—psoriasis	0.000508	0.00167	CcSEcCtD
Linagliptin—Angioedema—Mycophenolate mofetil—psoriasis	0.000495	0.00163	CcSEcCtD
Linagliptin—Malnutrition—Hydrocortisone—psoriasis	0.000494	0.00162	CcSEcCtD
Linagliptin—Hypersensitivity—Hydroxyurea—psoriasis	0.000493	0.00162	CcSEcCtD
Linagliptin—Cough—Cyclosporine—psoriasis	0.000485	0.00159	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000484	0.00159	CcSEcCtD
Linagliptin—Weight increased—Prednisone—psoriasis	0.00048	0.00158	CcSEcCtD
Linagliptin—Constipation—Mycophenolic acid—psoriasis	0.000479	0.00158	CcSEcCtD
Linagliptin—Myalgia—Cyclosporine—psoriasis	0.000473	0.00156	CcSEcCtD
Linagliptin—Arthralgia—Cyclosporine—psoriasis	0.000473	0.00156	CcSEcCtD
Linagliptin—Cough—Mycophenolate mofetil—psoriasis	0.000473	0.00156	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.00047	0.00154	CcSEcCtD
Linagliptin—Angioedema—Prednisolone—psoriasis	0.000462	0.00152	CcSEcCtD
Linagliptin—Myalgia—Mycophenolate mofetil—psoriasis	0.000462	0.00152	CcSEcCtD
Linagliptin—Arthralgia—Mycophenolate mofetil—psoriasis	0.000462	0.00152	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000458	0.00151	CcSEcCtD
Linagliptin—Diarrhoea—Hydroxyurea—psoriasis	0.000458	0.00151	CcSEcCtD
Linagliptin—Anaphylactic shock—Cyclosporine—psoriasis	0.000454	0.00149	CcSEcCtD
Linagliptin—Angioedema—Hydrocortisone—psoriasis	0.000451	0.00148	CcSEcCtD
Linagliptin—Infection—Cyclosporine—psoriasis	0.000451	0.00148	CcSEcCtD
Linagliptin—Back pain—Triamcinolone—psoriasis	0.00045	0.00148	CcSEcCtD
Linagliptin—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000442	0.00145	CcSEcCtD
Linagliptin—Skin disorder—Cyclosporine—psoriasis	0.000441	0.00145	CcSEcCtD
Linagliptin—Infection—Mycophenolate mofetil—psoriasis	0.00044	0.00144	CcSEcCtD
Linagliptin—Pancreatitis—Methotrexate—psoriasis	0.000432	0.00142	CcSEcCtD
Linagliptin—Skin disorder—Mycophenolate mofetil—psoriasis	0.00043	0.00141	CcSEcCtD
Linagliptin—Angioedema—Triamcinolone—psoriasis	0.000425	0.0014	CcSEcCtD
Linagliptin—Rash—Hydroxyurea—psoriasis	0.000422	0.00139	CcSEcCtD
Linagliptin—Dermatitis—Hydroxyurea—psoriasis	0.000422	0.00139	CcSEcCtD
Linagliptin—Myalgia—Hydrocortisone—psoriasis	0.000421	0.00138	CcSEcCtD
Linagliptin—Headache—Hydroxyurea—psoriasis	0.000419	0.00138	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000418	0.00137	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000413	0.00136	CcSEcCtD
Linagliptin—Anaphylactic shock—Prednisolone—psoriasis	0.000413	0.00136	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Methotrexate—psoriasis	0.00041	0.00135	CcSEcCtD
Linagliptin—Cough—Triamcinolone—psoriasis	0.000406	0.00133	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000403	0.00133	CcSEcCtD
Linagliptin—Anaphylactic shock—Hydrocortisone—psoriasis	0.000403	0.00133	CcSEcCtD
Linagliptin—Infection—Hydrocortisone—psoriasis	0.0004	0.00132	CcSEcCtD
Linagliptin—Myalgia—Triamcinolone—psoriasis	0.000396	0.0013	CcSEcCtD
Linagliptin—Infestation—Methotrexate—psoriasis	0.000393	0.00129	CcSEcCtD
Linagliptin—Infestation NOS—Methotrexate—psoriasis	0.000393	0.00129	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000392	0.00129	CcSEcCtD
Linagliptin—Skin disorder—Hydrocortisone—psoriasis	0.000392	0.00129	CcSEcCtD
Linagliptin—Constipation—Cyclosporine—psoriasis	0.000388	0.00127	CcSEcCtD
Linagliptin—Angioedema—Betamethasone—psoriasis	0.000386	0.00127	CcSEcCtD
Linagliptin—Angioedema—Dexamethasone—psoriasis	0.000386	0.00127	CcSEcCtD
Linagliptin—Diarrhoea—Mycophenolic acid—psoriasis	0.000384	0.00126	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000382	0.00126	CcSEcCtD
Linagliptin—Immune system disorder—Prednisone—psoriasis	0.000381	0.00125	CcSEcCtD
Linagliptin—Anaphylactic shock—Triamcinolone—psoriasis	0.00038	0.00125	CcSEcCtD
Linagliptin—Constipation—Mycophenolate mofetil—psoriasis	0.000378	0.00124	CcSEcCtD
Linagliptin—Infection—Triamcinolone—psoriasis	0.000377	0.00124	CcSEcCtD
Linagliptin—Malnutrition—Prednisone—psoriasis	0.000368	0.00121	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000367	0.00121	CcSEcCtD
Linagliptin—Urticaria—Cyclosporine—psoriasis	0.00036	0.00118	CcSEcCtD
Linagliptin—Myalgia—Betamethasone—psoriasis	0.000359	0.00118	CcSEcCtD
Linagliptin—Myalgia—Dexamethasone—psoriasis	0.000359	0.00118	CcSEcCtD
Linagliptin—Rash—Mycophenolic acid—psoriasis	0.000354	0.00116	CcSEcCtD
Linagliptin—Dermatitis—Mycophenolic acid—psoriasis	0.000353	0.00116	CcSEcCtD
Linagliptin—Urticaria—Mycophenolate mofetil—psoriasis	0.000352	0.00116	CcSEcCtD
Linagliptin—Headache—Mycophenolic acid—psoriasis	0.000351	0.00115	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000348	0.00114	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000346	0.00114	CcSEcCtD
Linagliptin—Anaphylactic shock—Betamethasone—psoriasis	0.000344	0.00113	CcSEcCtD
Linagliptin—Anaphylactic shock—Dexamethasone—psoriasis	0.000344	0.00113	CcSEcCtD
Linagliptin—Infection—Dexamethasone—psoriasis	0.000342	0.00112	CcSEcCtD
Linagliptin—Infection—Betamethasone—psoriasis	0.000342	0.00112	CcSEcCtD
Linagliptin—Angioedema—Prednisone—psoriasis	0.000336	0.0011	CcSEcCtD
Linagliptin—Hypersensitivity—Cyclosporine—psoriasis	0.000334	0.0011	CcSEcCtD
Linagliptin—Urticaria—Prednisolone—psoriasis	0.000328	0.00108	CcSEcCtD
Linagliptin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000326	0.00107	CcSEcCtD
Linagliptin—Urticaria—Hydrocortisone—psoriasis	0.00032	0.00105	CcSEcCtD
Linagliptin—Immune system disorder—Methotrexate—psoriasis	0.000319	0.00105	CcSEcCtD
Linagliptin—Mediastinal disorder—Methotrexate—psoriasis	0.000318	0.00105	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000314	0.00103	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000314	0.00103	CcSEcCtD
Linagliptin—Myalgia—Prednisone—psoriasis	0.000313	0.00103	CcSEcCtD
Linagliptin—Arthralgia—Prednisone—psoriasis	0.000313	0.00103	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000311	0.00102	CcSEcCtD
Linagliptin—Diarrhoea—Cyclosporine—psoriasis	0.00031	0.00102	CcSEcCtD
Linagliptin—Malnutrition—Methotrexate—psoriasis	0.000307	0.00101	CcSEcCtD
Linagliptin—Hypersensitivity—Prednisolone—psoriasis	0.000304	0.001	CcSEcCtD
Linagliptin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000303	0.000995	CcSEcCtD
Linagliptin—Urticaria—Triamcinolone—psoriasis	0.000302	0.000991	CcSEcCtD
Linagliptin—Anaphylactic shock—Prednisone—psoriasis	0.0003	0.000986	CcSEcCtD
Linagliptin—Infection—Prednisone—psoriasis	0.000298	0.000979	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000297	0.000977	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000297	0.000977	CcSEcCtD
Linagliptin—Back pain—Methotrexate—psoriasis	0.000297	0.000977	CcSEcCtD
Linagliptin—Hypersensitivity—Hydrocortisone—psoriasis	0.000297	0.000976	CcSEcCtD
Linagliptin—Skin disorder—Prednisone—psoriasis	0.000291	0.000958	CcSEcCtD
Linagliptin—Rash—Cyclosporine—psoriasis	0.000286	0.00094	CcSEcCtD
Linagliptin—Dermatitis—Cyclosporine—psoriasis	0.000286	0.000939	CcSEcCtD
Linagliptin—Headache—Cyclosporine—psoriasis	0.000284	0.000934	CcSEcCtD
Linagliptin—Hypersensitivity—Triamcinolone—psoriasis	0.00028	0.000919	CcSEcCtD
Linagliptin—Rash—Mycophenolate mofetil—psoriasis	0.000279	0.000917	CcSEcCtD
Linagliptin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000279	0.000916	CcSEcCtD
Linagliptin—Headache—Mycophenolate mofetil—psoriasis	0.000277	0.000911	CcSEcCtD
Linagliptin—Diarrhoea—Hydrocortisone—psoriasis	0.000276	0.000907	CcSEcCtD
Linagliptin—Urticaria—Betamethasone—psoriasis	0.000274	0.000899	CcSEcCtD
Linagliptin—Urticaria—Dexamethasone—psoriasis	0.000274	0.000899	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000273	0.000898	CcSEcCtD
Linagliptin—Cough—Methotrexate—psoriasis	0.000268	0.000881	CcSEcCtD
Linagliptin—Arthralgia—Methotrexate—psoriasis	0.000261	0.000859	CcSEcCtD
Linagliptin—Myalgia—Methotrexate—psoriasis	0.000261	0.000859	CcSEcCtD
Linagliptin—Rash—Prednisolone—psoriasis	0.00026	0.000855	CcSEcCtD
Linagliptin—Dermatitis—Prednisolone—psoriasis	0.00026	0.000855	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.00026	0.000854	CcSEcCtD
Linagliptin—Headache—Prednisolone—psoriasis	0.000259	0.00085	CcSEcCtD
Linagliptin—Constipation—Prednisone—psoriasis	0.000256	0.000843	CcSEcCtD
Linagliptin—Rash—Hydrocortisone—psoriasis	0.000254	0.000835	CcSEcCtD
Linagliptin—Dermatitis—Hydrocortisone—psoriasis	0.000254	0.000835	CcSEcCtD
Linagliptin—Headache—Hydrocortisone—psoriasis	0.000253	0.00083	CcSEcCtD
Linagliptin—Anaphylactic shock—Methotrexate—psoriasis	0.000251	0.000824	CcSEcCtD
Linagliptin—Infection—Methotrexate—psoriasis	0.000249	0.000819	CcSEcCtD
Linagliptin—Skin disorder—Methotrexate—psoriasis	0.000243	0.0008	CcSEcCtD
Linagliptin—Rash—Triamcinolone—psoriasis	0.000239	0.000787	CcSEcCtD
Linagliptin—Dermatitis—Triamcinolone—psoriasis	0.000239	0.000786	CcSEcCtD
Linagliptin—Urticaria—Prednisone—psoriasis	0.000238	0.000783	CcSEcCtD
Linagliptin—Headache—Triamcinolone—psoriasis	0.000238	0.000782	CcSEcCtD
Linagliptin—Diarrhoea—Dexamethasone—psoriasis	0.000236	0.000775	CcSEcCtD
Linagliptin—Diarrhoea—Betamethasone—psoriasis	0.000236	0.000775	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000228	0.000751	CcSEcCtD
Linagliptin—Hypersensitivity—Prednisone—psoriasis	0.000221	0.000726	CcSEcCtD
Linagliptin—Rash—Dexamethasone—psoriasis	0.000217	0.000714	CcSEcCtD
Linagliptin—Rash—Betamethasone—psoriasis	0.000217	0.000714	CcSEcCtD
Linagliptin—Dermatitis—Dexamethasone—psoriasis	0.000217	0.000713	CcSEcCtD
Linagliptin—Dermatitis—Betamethasone—psoriasis	0.000217	0.000713	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Methotrexate—psoriasis	0.000216	0.000711	CcSEcCtD
Linagliptin—Headache—Dexamethasone—psoriasis	0.000216	0.000709	CcSEcCtD
Linagliptin—Headache—Betamethasone—psoriasis	0.000216	0.000709	CcSEcCtD
Linagliptin—Diarrhoea—Prednisone—psoriasis	0.000205	0.000675	CcSEcCtD
Linagliptin—Urticaria—Methotrexate—psoriasis	0.000199	0.000655	CcSEcCtD
Linagliptin—Rash—Prednisone—psoriasis	0.000189	0.000622	CcSEcCtD
Linagliptin—Dermatitis—Prednisone—psoriasis	0.000189	0.000621	CcSEcCtD
Linagliptin—Headache—Prednisone—psoriasis	0.000188	0.000618	CcSEcCtD
Linagliptin—Hypersensitivity—Methotrexate—psoriasis	0.000185	0.000607	CcSEcCtD
Linagliptin—Diarrhoea—Methotrexate—psoriasis	0.000172	0.000564	CcSEcCtD
Linagliptin—Rash—Methotrexate—psoriasis	0.000158	0.000519	CcSEcCtD
Linagliptin—Dermatitis—Methotrexate—psoriasis	0.000158	0.000519	CcSEcCtD
Linagliptin—Headache—Methotrexate—psoriasis	0.000157	0.000516	CcSEcCtD
